Pharmaceutical Market Europe • November 2022 • 3

COMMENT

The age of diversity, equality and inclusion

In this issue, our cover article by Danny Buckland focuses on diversity in clinical trials. As Danny says: ‘The clinical trials system has often been labelled prehistoric, due to an inherent lack of inclusion and an inability to represent wider populations.

‘The FDA reported that, although 40% of the US population is from minority racial and ethnic groups, an overwhelming 75% of 32,000 participants in the trials of 53 approved novel drugs were white.  Teva, in its quest to promote greater diversity, underscored the issue by reporting on its website: ‘Only 30% of the participants were over 65 years of age and more than half of the patients were located in the US.’

‘The FDA’s insistence that more real-world evidence needs to be included in clinical trials is a major advance, but practical steps need to be taken to make it easier for patients to participate in trials.’ Read more on page 30.

In his article on page 16, Uday Bose, Country Managing Director at Boehringer Ingelheim UK and Ireland talks about the importance of involving the patient voice in digital transformation, and why the real drivers of change in digital transformation cannot be underestimated or left behind.

For those of you, like me, who eagerly anticipate the next excellent, thought-provoking column from Rohit Khanna in each issue, he’s taking a break this month, but I’m very pleased to say that he expects to be back next month to bring us more hard-hitting commentary on the state of the US healthcare system.

Looking ahead, our December issue will focus on the importance of corporate social responsibility (CSR), the importance of a good public image and how CSR strategies have been shaped by recent events. We’ll also look at how decentralised clinical trials can improve research and benefit patients.

If you would like to make your voice heard on these topics, please get in touch at sales@pmlive.com

I hope you enjoy this issue!

Image

Iona Everson
Group Managing Editor

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson

Journalist/editorial assistant
Fleur Jeffries
Emily Kimber


Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2022 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image